Point72 Asset Management, L.P. 13D/13G Filings for Fate Therapeutics, Inc. (FATE)

Point72 Asset Management, L.P. 13D and 13G filings for Fate Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
7:50 pm
Sale		 2024-09-30 13G Fate Therapeutics, Inc.
FATE		 Point72 Asset Management, L.P. 0
0.000%		 -4,945,146decrease
(Position Closed)		 Filing
2024-01-25
4:19 pm
Purchase		 2024-01-24 13G Fate Therapeutics, Inc.
FATE		 Point72 Asset Management, L.P. 4,945,146
5.000%		 4,945,146increase
(New Position)		 Filing